Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tay–Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum–associated degradation
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY OF THE CELL
Volume 27, Issue 24, Pages 3813-3827
Publisher
American Society for Cell Biology (ASCB)
Online
2016-09-29
DOI
10.1091/mbc.e16-01-0012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An intrinsic mechanism of secreted protein aging and turnover
- (2015) Won Ho Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remodeling the Proteostasis Network to Rescue Glucocerebrosidase Variants by Inhibiting ER-Associated Degradation and Enhancing ER Folding
- (2013) Fan Wang et al. PLoS One
- Characterization of the mutant β-subunit of β-hexosaminidase for dimer formation responsible for the adult form of Sandhoff disease with the motor neuron disease phenotype
- (2012) Kenichiro Yamada et al. JOURNAL OF BIOCHEMISTRY
- Selective Targeting of Proteins within Secretory Pathway for Endoplasmic Reticulum-associated Degradation
- (2012) Lara Vecchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
- (2012) Frances M. Platt et al. JOURNAL OF CELL BIOLOGY
- Inhibition of Endoplasmic Reticulum-associated Degradation Rescues Native Folding in Loss of Function Protein Misfolding Diseases
- (2011) Fan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Processing and turnover of the Hedgehog protein in the endoplasmic reticulum
- (2011) Xin Chen et al. JOURNAL OF CELL BIOLOGY
- Efficient Detection of Proteins Retro-Translocated from the ER to the Cytosol by In Vivo Biotinylation
- (2011) Gianluca Petris et al. PLoS One
- Chemical and Pharmacological Chaperones: Application for Recombinant Protein Production and Protein Folding Diseases
- (2010) Rahul S. Rajan et al. CURRENT MEDICINAL CHEMISTRY
- Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LSsubstrates
- (2010) Riccardo Bernasconi et al. JOURNAL OF CELL BIOLOGY
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs
- (2010) Etty Osher et al. MOLECULAR GENETICS AND METABOLISM
- In Search of a Solution to the Sphinx-Like Riddle of GM1
- (2010) Robert W. Ledeen et al. NEUROCHEMICAL RESEARCH
- Human OS-9, a Lectin Required for Glycoprotein Endoplasmic Reticulum-associated Degradation, Recognizes Mannose-trimmedN-Glycans
- (2009) Nobuko Hosokawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Getting In and Out from Calnexin/Calreticulin Cycles
- (2008) Julio J. Caramelo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural consequences of amino acid substitutions causing Tay–Sachs disease
- (2008) Kazuki Ohno et al. MOLECULAR GENETICS AND METABOLISM
- OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1–SEL1L ubiquitin ligase complex for ERAD
- (2008) John C. Christianson et al. NATURE CELL BIOLOGY
- SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins
- (2008) B. Mueller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started